Labshake search
Citations for BioLegend :
1 - 50 of 375 citations for CD35 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2019Quote: ... CD21/CD35-Biotin (Biolegend, clone 7E9), Ki-67 (Biolegend ...
-
bioRxiv - Immunology 2021Quote: ... anti-CD21/CD35-PE (7E9, BioLegend), anti-CD5-APC (53-7.3 ...
-
bioRxiv - Immunology 2021Quote: ... anti-CD21/CD35-FITC (7E9, BioLegend), anti-CD21/CD35-PE (7E9 ...
-
bioRxiv - Bioengineering 2023Quote: ... anti-mouse CD21/CD35 PE (Biolegend, Cat: #123410), anti-mouse CD69 PE (Biolegend ...
-
bioRxiv - Immunology 2024Quote: ... anti-mouse CD21/CD35 (Alexa Fluor® 594, Biolegend), and anti-mouse IgD (Alexa Fluor® 647 anti-mouse IgD ...
-
bioRxiv - Immunology 2020Quote: ... Biotinylated CD35 was detected with BV421-conjugated streptavidin (BioLegend, #405225) for 2hr at room temperature ...
-
bioRxiv - Cancer Biology 2021Quote: ... CD35-PE (#333405) and PDPN-APC (#337021) or control isotypes antibodies (Biolegend). Then ...
-
bioRxiv - Immunology 2023Quote: ... The phenotype of differentiated HL-60 cells was assessed by flow cytometry using mouse antihuman CD35 PE conjugated antibody (BioLegend) and mouse anti-human CD71 APC conjugated antibody (BioLegend) ...
-
bioRxiv - Microbiology 2023Quote: ... Antibodies used were Fluoroscein isothiocyanate (FITC)-conjugated anti-mouse CD4 and CD21/CD35 (CR2/CR1: Biolegend, San Diego, CA, USA) and Phycoerythrin (PE)-conjugated anti-mouse CD3 (17A2 ...
-
bioRxiv - Systems Biology 2019Quote: ... FcX blocking solution (BioLegend) was added in a dilution of 1:50.
-
bioRxiv - Cell Biology 2020Quote: ... FcX blocking solution (BioLegend) was added at a dilution of 1:50.
-
bioRxiv - Immunology 2021Quote: Monocyte blocking solution (BioLegend) and Brilliant Stain Buffer (BD ...
-
bioRxiv - Immunology 2021Quote: ... Fc-blocking reagent (Biolegend, 422301) was used to block Fc receptor-introduced non-specific staining ...
-
bioRxiv - Genomics 2024Quote: ... Fc-blocking reagent (BioLegend, 422301) was used to block Fc receptor-introduced nonspecific staining ...
-
bioRxiv - Cancer Biology 2021Quote: ... blocked with FcX blocking buffer (BioLegend) for 10 minutes on ice and then incubated with hash-antibodies (TotalSeq from BioLegend ...
-
bioRxiv - Immunology 2020Quote: ... CD112 blocking antibody (clone TX31, Biolegend), 10 μM LY2109761 ...
-
bioRxiv - Immunology 2020Quote: ... CD44 blocking antibody (clone IM7, Biolegend), ILT-2 (CD85J ...
-
bioRxiv - Cancer Biology 2019Quote: ... and Fc receptor blocking solution (Biolegend), before staining with fluorochrome-conjugated anti-human antibodies specific to anti-CD3 (UCHT1)/anti-CD45 (2D1) ...
-
bioRxiv - Neuroscience 2022Quote: ... After fragment crystallizable (Fc) blocking (Biolegend), cells were stained for surface antigens (Extended Data Table 4) ...
-
bioRxiv - Immunology 2020Quote: ... CD25 blocking antibodies (Clone 3C7, BioLegend) were added to culture media prior to T cell stimulation ...
-
bioRxiv - Immunology 2023Quote: ... blocked with FcR blocking reagent (BioLegend) on ice for 10 min and then incubated with surface antibody cocktail for 30 min in dark ...
-
bioRxiv - Immunology 2023Quote: ... underwent blocking in TruStainFcX (Biolegend, 422302) for 10 min and were stained with a mixture of EPCAM (anti-CD326 PE ...
-
bioRxiv - Immunology 2023Quote: ... After Fc blocking (TruStain FcX; BioLegend), cells were stained with a metal-conjugated surface antibody cocktail (Table 2) ...
-
bioRxiv - Cancer Biology 2023Quote: ... performed with Fc blocking (422302, BioLegend), and labelled with anti-CD138 (142508 ...
-
bioRxiv - Immunology 2023Quote: ... DQ blocking antibody (Biolegend, Cat# 361702) were included to confirm MHC dependent IFNγ release.
-
bioRxiv - Immunology 2021Quote: ... 20 µL diluted peptide and 20µL 1µg/mL UV-sensitive peptide HLA-A2 monomer (BioLegend) were added into 96-well plates and mixed well by pipetting up and down ...
-
bioRxiv - Immunology 2021Quote: ... VEGFA blocking antibody (BioLegend, 2G11-2A05, 50μg) was administered intravenous ...
-
bioRxiv - Immunology 2020Quote: ... Fc receptor blocking antibody (CD16/CD32; Biolegend), anti-EpCAM (clone G8.8 ...
-
bioRxiv - Immunology 2022Quote: ... Fc receptor-blocking antibody (CD16/CD32; BioLegend), anti-EpCAM (clone G8.8 ...
-
bioRxiv - Immunology 2020Quote: ... Pre-blocking step with TruStain FcX (BioLegend) was included for all staining ...
-
bioRxiv - Immunology 2022Quote: ... 10 µl TruStain FcX blocking reagent (BioLegend) was added ...
-
bioRxiv - Immunology 2022Quote: After Fc-blocking using FcX reagents (BioLegend), cells were incubated with primary antibodies in FACS buffer for 30 min at 4°C and if necessary ...
-
bioRxiv - Genomics 2022Quote: ... FcX blocking solution (BioLegend catalogue no. 101319) was added at a dilution of 1:50 ...
-
bioRxiv - Systems Biology 2022Quote: ... Human TruStain FcX FC blocking reagent (BioLegend) was added according to manufacturers’ instructions for 10min on ice ...
-
bioRxiv - Immunology 2023Quote: ... blocking antibodies to TNFa (MAb-1, Biolegend) were added at a concentration of 1 ug/mL ...
-
bioRxiv - Immunology 2023Quote: ... HLA-ABC blocking antibody (Biolegend, Cat# 311428) and HLA-DR ...
-
bioRxiv - Immunology 2024Quote: ... Human TrueStain FcX blocking solution (Biolegend, 422302) was added to cells for 10 min before staining ...
-
bioRxiv - Immunology 2024Quote: ... PD-1 blocking antibody (29F.1A12, Biolegend) was freshly added (10μg/ml ...
-
bioRxiv - Immunology 2022Quote: ... Cells were washed three times in ice cold blocking buffer and re-suspended in blocking buffer containing 0.1 μg/ml DAPI (Biolegend, USA).
-
bioRxiv - Cancer Biology 2023Quote: ... 100 000-200 000 cells per sample were processed by blocking with 5 µl of Human TruStain FcX Blocking Solution (BioLegend) for 10 min at 4°C ...
-
bioRxiv - Developmental Biology 2021Quote: ... 0.25ug of TruStain FcX™ Blocking reagent (Biolegend) was added for 10 minutes on ice ...
-
bioRxiv - Genomics 2020Quote: ... and 5 μL TruStain FcX blocking antibodies (Biolegend) were added and incubated for 10 minutes on ice ...
-
bioRxiv - Immunology 2020Quote: ... HLA-ABC blocking antibody (clone W6/32, Biolegend), CD44 blocking antibody (clone IM7 ...
-
bioRxiv - Immunology 2020Quote: ... 2 μl of Trustain FcR blocking reagent (BioLegend), 3 μl of anti-human CD45 antibody (clone HI100 ...
-
bioRxiv - Cancer Biology 2019Quote: ... or PD-1 blocking Ab (clone EH12.2H7, BioLegend) were added to the media and incubated at 37 °C for 72 hrs ...
-
bioRxiv - Microbiology 2020Quote: ... Following blocking with FcγR antibody (BioLegend, clone 93), cells were stained on ice with CD45 BUV395 (BD BioSciences clone 30-F11) ...
-
bioRxiv - Cancer Biology 2021Quote: ... after incubation with an Fc blocking antibody (Biolegend). Finally ...
-
bioRxiv - Immunology 2023Quote: ... Human TruStain FcX (Fc receptor blocking solution, BioLegend) was used to avoid nonspecific binding ...
-
bioRxiv - Immunology 2023Quote: ... blocking or anti-TNFR2 monoclonal antibody (358408, Biolegend) or its isotype control (400544 ...
-
bioRxiv - Bioengineering 2023Quote: ... followed by blocking with Trustain FcX solution (Biolegend) and staining with anti-human CD33 antibody conjugated to Brilliant Violet 605 (BV605 ...